Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 12:03 pm Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | MRL Ventures Fund LLC | 1,739,768 5.600% | 1,739,768 (New Position) | Filing History |
| 2022-02-04 09:17 am Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Wellington Management Group LLP | 3,114,006 9.980% | 3,114,006 (New Position) | Filing History |
| 2021-12-16 5:23 pm Unchanged | 2021-12-14 | 13D | Entrada Therapeutics, Inc. TRDA | Baker Bros. Advisors LP | 4,704,419 15.100% | 0 (Unchanged) | Filing History |
| 2021-11-12 4:30 pm Purchase | 2021-11-02 | 13D | Entrada Therapeutics, Inc. TRDA | 5AM Ventures V, L.P. | 4,409,687 14.800% | 4,409,687 (New Position) | Filing History |
| 2021-11-12 4:07 pm Purchase | 2021-11-02 | 13D | Entrada Therapeutics, Inc. TRDA | MPM BioVentures 2014, L.P. | 4,427,092 14.800% | 4,427,092 (New Position) | Filing History |
| 2021-11-10 4:50 pm Purchase | 2021-11-02 | 13G | Entrada Therapeutics, Inc. TRDA | Baker Bros. Advisors LP | 4,704,419 15.100% | 4,704,419 (New Position) | Filing History |